Bogart Wealth, LLC Moderna, Inc. Transaction History

Bogart Wealth, LLC

$2.1 Billion
Q3 2024

A detailed history of Bogart Wealth, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Bogart Wealth, LLC holds 127 shares of MRNA stock, worth $4,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127

Previous 127 -0.0%

Holding current value

$4,679

Previous $15,000 46.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$101.21 - $166.61 $708 - $1,166	7 Added 5.83%	127 $15,000
Q1 2024 Apr 25, 2024	BUY	$85.37 - $115.44 $426 - $577	5 Added 4.35%	120 $12,000
Q1 2023 Apr 21, 2023	SELL	$135.66 - $197.02 $2,713 - $3,940	-20 Reduced 14.81%	115 $17,000
Q4 2022 Feb 06, 2023	SELL	$118.38 - $210.04 $5,919 - $10,502	-50 Reduced 27.03%	135 $24,000
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $8,264 - $13,592	70 Added 60.87%	185 $22,000
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $2,342 - $3,531	-20 Reduced 14.81%	115 $16,000
Q1 2022 Apr 22, 2022	SELL	$126.46 - $235.05 $1,896 - $3,525	-15 Reduced 10.0%	135 $23,000
Q4 2021 Jan 19, 2022	SELL	$225.82 - $368.51 $1,129 - $1,842	-5 Reduced 3.23%	150 $38,000
Q2 2021 Aug 06, 2021	SELL	$129.91 - $234.98 $256,572 - $464,085	-1,975 Reduced 92.72%	155 $36,000
Q1 2021 Apr 16, 2021	BUY	$109.18 - $185.98 $230,369 - $392,417	2,110 Added 10550.0%	2,130 $279,000
Q4 2020 Jan 14, 2021	BUY	$65.74 - $169.86 $1,314 - $3,397	20 New	20 $2,000
Q3 2020 Oct 06, 2020	SELL	$54.34 - $94.85 $5,434 - $9,485	-100 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$29.67 - $80.0 $2,967 - $8,000	100 New	100 $6,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.

Account

Bogart Wealth, LLC Moderna, Inc. Transaction History